AIM:To analyze the proteins included in exosomes derived from blood of patients with hypertension and seek the main pathologi -cal changes in hypertension .METHODS:Forty-seven patients and healthy subjects were recruited and divided into two comparisons :healthy subjects vs atherosclerosis ( HS vs AS) , and atherosclerosis vs hypertension plus atherosclerosis ( AS vs HT+AS) .We extrac-ted exosomes from blood and utilized LC-MS/MS to identify the protein expression .We used GO analysis to established the hierarchy programs of biological process and molecular function .PPI was used to find the proteins related to the terms .RESULTS:It was found that three final child terms repeatedly shown in BP of the two categories ( HS vs AS and AS vs HT+AS):“signal transduction in re-sponse to DNA damage”,“response to zinc ion”, and“platelet aggregation”.It was found that two final child terms in MF of the two categories:“interleukin 2 receptor binding” and“ploy(A) RNA binding”.The proteins, PSMA6, PSMA7 and CA2, were related to the terms in the two categories .CONCLUSION: We discovered that the exosome proteins may indicate the pathological changes in hypertension through the biological processes related with the specific proteins .These specific proteins, such as VCL, PSMA6, DP, AKAP, ATP5B and CA2, can be the new indicators for severity of hypertension and new therapeutic targets .
作者: 刊期: 2016年第08期
目的:研究全反式维甲酸( all-trans retinoic acid,ATRA)对胃癌细胞SGC-7901存活率与放射敏感性的影响,并讨论其可能的机制。方法:MTT法检测细胞存活率;平板克隆形成实验和流式细胞术分别检测细胞的放射敏感性和细胞周期;实时荧光定量PCR( RT-qPCR)检测细胞中Bax、Bcl-2、survivin与NF-κB的mRNA表达。结果:ATRA可降低SGC-7901细胞存活率,当浓度到达8μmol/L时,抑制作用达到大;ATRA联合X射线处理后,与单纯放射处理相比,平均致死剂量(D0)和准阈剂量(Dq)显著变小(P<0.05),且拟合的生存曲线明显下移;ATRA能显著降低放射诱导的细胞G2/M期阻滞,下调SGC-7901细胞Bcl-2与survivin的mRNA表达( P<0.05),上调Bax与NF-κB的mRNA表达(P<0.05)。结论:ATRA能够增加胃癌细胞SGC-7901的凋亡及放射敏感性,可能与抑制细胞周期G2/M期的阻滞作用、下调Bcl-2与survivin mRNA表达和上调NF-κB与Bax mRNA表达有关。
作者:王艳萍;赵先群;张向东;许威;向晓辉 刊期: 2016年第08期
目的:感染负荷被认为是动脉粥样硬化( AS)新的独立危险因素。金黄色葡萄球菌( S.aureus)是临床常见的致病菌之一。本课题组前期研究发现,金黄色葡萄球菌超抗原样蛋白-5(SSL5)可以激活血小板。我们推测,SSL5可能通过激活血小板而诱发炎症反应,探讨其机制可以为阐明感染负荷在AS中的作用提供新的实验证据。方法:体外培养人外周血单核细胞及THP-1细胞,以SSL5激活血小板所产生的微粒( SSL5-PMPs)作用于上述细胞。结果:SSL5-PMPs呈时间和剂量依赖性地促进单核细胞IL-1β、TNF-α、MCP-1和MMP-9的表达;并促进MCP-1诱导的单核细胞迁移;阻断CD40L与CD40的相互作用,可以部分抑制SSL5-PMPs诱导单核细胞产生炎症介质;以siRNA下调单核细胞CD40或TRAF6基因的表达,导致SSL5-PMPs诱导单核细胞炎症介质的产生减少,并抑制NF-κB p65亚单位的磷酸化及核转位;阻断TLR4信号通路对SSL5-PMPs诱导单核细胞释放炎症介质没有影响。结论:SSL5可以激活血小板并产生PMPs;SSL5-PMPs与单核细胞结合,且主要与外周血中的具有促炎作用的单核细胞结合,促进炎性细胞因子的释放,CD40-TRAF6-NF-κB信号通路主要参与了这一过程。本研究为阐明感染负荷的致动脉粥样硬化机制提供了依据。
作者:胡厚源;贝俊杰;肇炜博 刊期: 2016年第08期
目的:组蛋白乙酰化修饰是表观遗传调控中重要的调控方式之一,组蛋白乙酰化与基因活化关系密切,其中一个重要环节是被特定阅读器结构域所识别,从而招募染色质调控因子到特定区域,协同完成基因表达调控。 AF9是这类阅读器之一,其是否参与心脏发育分化还未清楚。因此本研究探讨心脏转录因子联合AF9是否对心脏祖细胞的产生具有促进作用。方法:采用蛋白重组表达方式获得心脏转录因子GATA4、NKX2.5、TBX5(GNT)及AF9,结合纳米转导技术高效转导到目的细胞BM-SCs细胞核内,检测细胞毒性,CPCs的生成效率,组蛋白H3K9乙酰化情况,ChIP-PCR技术检测H3K9ac的作用靶点。结果:心脏转录因子GNT联合AF9能提高BMSCs重编程生成CPCs的效率,在200μg/L/蛋白的工作浓度下,细胞生长良好,与GNT组相比,联合AF9组的H3K9ac表达明显增加,ChIP-PCR的结果显示H3K9ac富集在MEF2C的启动子区域。结论:心脏转录因子组合GNT联合表观遗传调控因子AF9通过纳米-蛋白转导方式,能高效重编程BMSCs得到CPCs,AF9通过上调H3K9ac来促进重编程过程。
作者:李晓红;杨翔宇;吴岳恒;单志新;潘宇;雷和平;林秋雄;余细勇 刊期: 2016年第08期
目的:探讨高盐饮食对Dahl盐敏感大鼠肾小管上皮向间质转化( EMT )和肾脏纤维化的影响。方法:7~8周龄雄性Dahl盐敏感大鼠(SS, n=24)及SS-13BN大鼠(13BN, n=12),高盐、正常饮食干预4周与8周,测血压及血尿生化指标;用Masson染色评估肾脏纤维化程度;免疫组化和实时定量PCR检测肾小管上皮标志E-cadherin和间质细胞标志α-SMA mRNA和蛋白的表达情况。结果:(1)相较基线期,SS和13BN大鼠干预后收缩压增高,SS大鼠增高幅度更为明显;8周高盐干预时血压显著高于4周(P<0.01)。(2)4周高盐负荷后,2种大鼠肾脏均出现胶原纤维沉积,且SS高盐组多于13BN高盐组。8周时, SS高盐组肾小球和间质胶原沉积较4周进一步加重。(3)4周和8周高盐干预后,与SS正常饮食组相比,SS高盐组肾脏E-cadherin表达显著减少,α-SMA 表达明显增加。(4)肾脏纤维化程度与与肾小管EMT 的发生显著相关( E-cadherin: r =-0.787;α-SMA:r=0.866)。结论:高盐饮食可诱导Dahl盐敏感大鼠肾小管上皮细胞EMT的发生,促进肾脏纤维化。
作者:汪洋;牟建军;褚超;吕永波 刊期: 2016年第08期
目的:观察胰腺β细胞中电导钙激活钾离子通道(intermediate-conductance Ca2+-activated K +channel, KCa3.1)在2型糖尿病发病中的作用及调节机制。方法:应用2型糖尿病小鼠(db/db)模型,测评阻断KCa3.1对2型糖尿病表型指标的影响。分离小鼠胰腺β细胞,观察分别阻断KCa3.1和NF-κB信号通路对高糖或软脂酸诱导的NF-κB下游炎性细胞因子释放的影响。结果:KCa3.1阻断剂TRAM-34可降低db/db小鼠随时血糖水平。连续用药8周后,TRAM-34可降低db/db小鼠空腹血糖,改善葡萄糖耐量,增加餐后胰岛素水平,减轻db/db小鼠胰腺炎症并延缓β细胞的消亡。但TRAM-34不影响正常饮食C57BL/6小鼠空腹血糖和餐后血糖水平,无低血糖副作用。在分离的小鼠胰腺β细胞,分别阻断KCa3.1和NF-κB可降低高糖或软脂酸所引起的炎性趋化因子(CCL2和CCL20)的释放。结论:NF-κB活化介导胰腺β细胞KCa3.1上调,协同调节炎性细胞因子和胰岛素分泌,促发胰岛炎症和β细胞功能障碍,导致2型糖尿病。
作者:庞正达;王晓静;佘刚;邓秀玲 刊期: 2016年第08期
目的:葡萄糖转运体4(GLUT4)在球囊损伤血管新生内膜中高表达,而其转位过程依赖于肌动蛋白(actin)细胞骨架的调节。平滑肌蛋白22α( smooth muscle protein 22α,SM22α)是一种actin细胞骨架相关蛋白,其在增殖性血管疾病中表达下调。本研究观察了SM22α是否参与血管损伤或者PDGF刺激诱导的GLUT4表达和转位活性升高。方法:用PDGF-BB刺激血管平滑肌细胞( vascular smooth muscle cell , VSMC),观察GLUT4膜转位和细胞骨架的变化;用荧光葡萄糖2-NBDG检测葡萄糖摄取;用特异性siRNA敲低内源性SM22α表达;BrdU实验检测细胞增殖;高效液相色谱法检测组织葡萄糖含量。结果:PDGF-BB诱导VSMCs GLUT4转位和葡萄糖摄取依赖于皮层F-actin聚合,而敲低SM22α促进这一过程。损伤新生内膜处GLUT4表达显著增加,PDGF-BB刺激促进细胞GLUT4表达和葡萄糖消耗,抑制GLUT4活性则显著降低细胞增殖活性。相对于WT组, SM22α-/-小鼠颈总动脉2-NBDG摄取显著增加,结扎后28 d新生内膜明显增厚,损伤动脉组织GLTU4转位和葡萄糖含量均明显升高。结论:PDGF-BB诱导的GLUT4转位和糖摄取参与VSMCs 增殖。缺失SM22α可诱导皮层细胞骨架聚合,增强PDGF-BB诱导的GLUT4膜转位和糖摄取及代谢活性。 SM22α是一种新的增殖相关糖代谢调节因子。
作者:赵丽丽;陈鹏;谢肖立;窦永青;聂磊;林燕玲;李晓坤;苗穗兵;董丽华;尹亚娟;张丹丹;宋昱;韩梅 刊期: 2016年第08期
AIM:Heart failure is characterized by immune activation leading to production and release of proinflammatory cytokines .Inter-leukin 17A (IL-17A) is a proinflammatory cytokine and multiple lines of evidence from animal and human studies suggest crucial roles of IL-17A in heart failure.Therefore, we investigated whether common polymorphisms of genes IL17A and IL17RA (coding interleukin 17 receptor A) gene contribute to genetic predisposition to heart failure and adverse clinical outcomes associated with it .METHODS AND RESULTS:A total of 1713 adults patients with congestive heart failure and 1713 age-and sex-matched controls were genotyped for promoter SNPs, rs2275913 and rs8193037 in IL17A and rs4819554 in IL17RA, to assess the relationship between individual SNPs and the risk of congestive heart failure .Results showed that rs8193037 in IL17A was associated with the risk of congestive heart failure (P<0.01) after adjustment for multiple cardiovascular risk factors including age , sex, smoking status, diabetes, hypertension and dyslipidemia.This association was evident in both ischemic and non-ischemic heart failure (P<0.05).Furthermore, prospective fol-low-up of 12.7 months for the occurrence of adverse clinical outcomes showed that rs 4819554 in IL17RA was significantly associated with cardiovascular mortality (P<0.05) after adjustments for multiple cardiovascular risk factors and New York Heart Association functional class.CONCLUSION:This study demonstrated associations of rs8193037 in the promoter of IL17A with the risk of conges-tive heart failure, and of rs4819554 in the promoter of IL17RA with the risk of cardiovascular mortality in patients with congestive heart failure.These data lend further support to the notion that immune activation and genetic polymorphisms contribute to heart failure path -ogenesis and progression .
作者: 刊期: 2016年第08期
AIM:Mitochondrial DNA (mtDNA) copy number variation (CNV), which reflects the oxidant-induced cell damage, has been observed in a wide range of human diseases .However, whether it correlates with heart failure , which is closely related to oxidative stress, has never been elucidated before .We aimed to systematically investigate the association between leukocyte mtDNA CNV and heart failure risk and prognosis .METHODS: A total of 1 700 hospitalized patients with heart failure and 1 700 age-and gender-matched community population were consecutively enrolled in this observational study , as well as 1 638 ( 96.4%) patients were fol-lowed prospectively for a median of 17 months (12~24 months).The relative mtDNA copy number in leukocyte of peripheral blood or cardiac tissue was measured in triplicate by quantitative real-time PCR method .RESULTS:Patients with heart failure possessed much lower relative mtDNA copy number compared with control subjects (P<0.01), especially for the patients with ischemic etiology (P<0.01).Patients with lower mtDNA copy number exhibited 1.7 times higher risk of heart failure ( P<0.01).Long-term follow-up (median 17 months) showed that decreased mtDNA copy number was significant associated with both increased cardiovascular deaths (P<0.01) and cardiovascular rehospitalization (P<0.01).After adjusted for the conventional risk factors and medications , lower mtDNA copy number were still significantly associated with 50% higher cardiovascular mortality (P <0.05).CONCLUSION:mtDNA copy number depletion is an independent risk factor for heart failure and predicted higher risk of cardiovascular deaths in patients with heart failure .
作者: 刊期: 2016年第08期
目的:探讨梅花鹿二杠茸和三岔茸水提物对顺铂( CDDP)所致小鼠肾损伤的影响。方法:采用灌胃给药方式,用顺铂(15 mg/kg)诱导小鼠肾损伤模型,测定小鼠肾脏指数(KI)、血清肌酐(SCr)、血尿素氮(BUN)、肾脏组织中超氧化物歧化酶( SOD)和谷胱甘肽过氧化物酶( GSH-Px)活性及丙二醛( MDA)含量,并对肾脏组织进行HE染色,观察肾脏病理学变化,研究梅花鹿二杠茸和三岔茸的水提物各剂量对小鼠肾损伤的影响。结果:与顺铂组相比,各剂量鹿茸水提物可显著降低CDDP诱导肾损伤小鼠SCr、BUN水平及肾脏MDA含量,提高SOD和GSH-Px的活性( P<0.05);明显改善肾组织病理学形态,减轻CDDP对肾小管上皮细胞的损伤程度,且同等浓度下,与三岔茸相比,二杠茸水提物能更好地改善肾功能及减轻病理损伤。结论:鹿茸水提物减轻顺铂引起的小鼠肾损伤,其作用机制可能与鹿茸水提物增强小鼠肾脏组织的抗氧化能力有关。
作者:董思敏;王海璐;王全凯;张晶 刊期: 2016年第08期
目的:利用Sprague-Dawley( SD)大鼠AMI模型评价Rho激酶抑制剂法舒地尔对心梗后心室重构的改善作用及其相关机制。方法:通过结扎左前降支冠脉法制备大鼠急性心梗( AMI)模型40只,随机分为AMI组,法舒地尔低、中、高剂量治疗组和卡维地洛治疗组,另设假手术组。连续给药4周后,进行超声心动图检测心功能指标,同时留取大鼠心肌组织标本检测Rho激酶、TGF-β1、Bax、Bcl-2、MMP-9表达和Smad2/Smad3信号通路的激活状态。结果:(1)超声心动图检测显示:与AMI组比较,法舒地尔3个治疗组对AMI后心室重构均有明显抑制作用,以中剂量组佳。(2)与AMI组比较,治疗组Rho激酶和TGF-β1的mRNA水平、Bax和MMP-9蛋白表达水平明显降低,Bcl-2水平升高,Smad2/Smad3信号通路激活程度明显降低(P<0.05)。结论:法舒地尔可抑制大鼠心梗后的心室重构。
作者:符永恒;李桃;杨敏;林秋雄;王映辉;张梦珍;朱杰宁;李怡;刘晓颖;单志新 刊期: 2016年第08期
目的:随着饮食习惯和生活方式改变,非酒精性脂肪肝发病率近十年来明显增高。 FXR在胆汁酸代谢及糖脂代谢中起重要作用, FXR硫氢化修饰后对糖脂代谢影响机制尚不清楚。方法:本研究主要用modified biotin switch assay 检测FXR硫氢化修饰。分别用CSE腺病毒和siRNA过表达和敲低H2 S观察FXR变化。 Real-time PCR和Weastern blot等方法检测FXR及下游信号通路关键分子mRNA和蛋白水平变化。用高脂喂养小鼠给予H2 S供体,观察肝脏形态学变化。结果:内源性和外源性H2 S都可使FXR发生硫氢化修饰,并增强其转录活性,抑制糖脂代谢关键分子SREBP1-C表达,其下游FAS、ACC、PEPCK、G6Pase等脂肪酸从头合成基因和糖异生基因受到抑制,动物实验部分高脂饮食小鼠给予H2 S供体腹腔注射后,肝脏HE染色和油红O染色均表明脂滴变小,脂肪肝减轻。结论:研究提示FXR硫氢化修饰后抑制脂质合成,减轻脂肪肝。
作者:徐文静;范静慧;杜从阔;林宪娟;郑凤娇;蔡君艳;耿彬 刊期: 2016年第08期
AIM:To investigate whether KCNE 2 participates in the development of pathological hypertrophy .METHODS:Bidirectional ma-nipulations of KCNE2 expression were performed by adenoviral overexpression of KCNE 2 or knockdown of KCNE2 with RNA interfer-ence in PE-induced neonatal rat ventricular myocytes .Then overexpression of KCNE 2 in mouse model of left ventricular hypertrophy in-duced by transverse aortic constriction (TAC) by ultrasound microbubble-mediated gene transfer were used to detect the therapeutic function of KCNE2 in the development of hypertrophy .RESULTS:KCNE2 expression was significantly decreased in PE-induced hy-pertrophic cardiomyocytes and in hypertrophic hearts produced by TAC .Knockdown of KCNE2 in cardiomyocytes reproduced hypertro-phy, whereas overexpression of KCNE2 attenuated PE-induced cardiomyocyte hypertrophy .Knockdown of KCNE2 increased calcineurin activity and nuclear NFAT protein level , and pretreatment with nifedipine or FK 506 attenuated decreased KCNE 2-induced cardiomyo-cyte hypertrophy .Overexpression of KCNE 2 in heart by ultrasound microbubble-mediated gene transfer suppressed the development of hypertrophy and activation of calcineurin-NFAT and MAPK pathways in TAC mice .CONCLUSION:These findings demonstrate that cardiac KCNE2 expression is decreased and contributes to the development of hypertrophy via activation of calcineurin -NFAT andMAPK pathways .
作者: 刊期: 2016年第08期
目的:探讨儿茶酚抑素( CST)对间歇低氧高血压大鼠的作用及机制。方法:健康雄性SD大鼠随机分为3组:control组、IH (间歇低氧组)组和IH+CST组(于低氧前3 d皮下埋植含CST 20 nmol? kg -1? d-1的微量渗透泵)。后2组置于间歇低氧舱中,舱内氧浓度为(5±0.5)%~(21±0.5)%,低氧-复氧循环时间为120 s(60 s+60 s),8 h/d,共3周。颈总动脉插管测收缩压(SP)、舒张压(DP)和平均压(MP),检测血浆中氧化/抗氧化损伤指标,Western blot 法检测主动脉和肾组织中核因子E2相关因子2(Nrf2)蛋白表达的变化。结果:SP、DP及MP,IH组均比control 组高(P<0.01),而IH+CST 组则显著低于IH 组(P<0.01)。 IH组的MPO和MDA含量显著高于control组(P<0.05),而SOD和羟自由基抑制率显著低于control组(P<0.01);IH+CST组的MPO和MDA明显低于IH组(P<0.05),SOD和羟自由基抑制率显著高于IH组(P<0.01)。与control组相比, IH组大鼠主动脉和肾组织胞浆、胞核中Nrf2蛋白的表达均显著下调(P<0.05);IH+CST组与IH组相比,胞浆中Nrf2蛋白的表达显著下调(P<0.05),而胞核中Nrf2蛋白的表达显著上调(P<0.05)。结论:CST有减轻间歇低氧致大鼠高血压的作用,该作用可能与其通过Nrf2-ARE信号通路调节氧化应激反应有关。
作者:陈然;范小芳;郑青青;丁露;薛峰;王永煜;龚永生 刊期: 2016年第08期
目的:平滑肌蛋白22α( smooth muscle protein 22α,SM22α)被视为是细胞衰老的标志物,但是其在血管平滑肌细胞( vascu-lar smooth muscle cell ,VSMC)衰老过程中的作用尚不清楚。本研究旨在探讨SM22α在VSMC衰老和血管老化进程中的作用。方法:利用angiotensin II(Ang II,10-7 mol/L)慢性刺激诱导VSMC衰老;用野生型和SM22α基因敲除小鼠皮下植泵,持续灌注Ang II(1μg? kg-1? min-1)4周,复制高血压模型。通过敲低和过表达SM22α观察其对VSMC衰老及调控通路蛋白表达和活性的影响。结果:Ang II持续刺激可诱导VSMC衰老,伴随着SM22α的表达增高。敲低SM22α可减弱Ang II诱导的VSMC衰老,过表达则反之。在Ang II诱导VSMC衰老条件下,SM22α表达上调抑制Mdm2与p53的结合,上调p53含量。 SM22α表达增加抑制Akt与Mdm2的磷酸化活化,导致Mdm2与p53的结合减弱。 SM22α基因敲除改善Ang II诱导的主动脉VSMC衰老和血压升高。结论:SM22α表达上调抑制Akt/Mdm2通路激活,进而减弱Mdm2与p53的结合,上调p53的表达量,促进衰老。
作者:苗穗兵;谢肖立;尹亚娟;赵丽丽;舒亚南;陈荣;陈鹏;董丽华;林燕玲;吕品;张丹丹;聂茜;薛震颖;韩梅 刊期: 2016年第08期
目的:探讨核仁素对心肌梗死后巨噬细胞极化的影响及其作用机制。方法:采用小鼠心肌梗死模型;采用心肌内注射核仁素RNA干扰的慢病毒载体,从整体水平观察核仁素低表达对小鼠心梗后死亡率的影响及对巨噬细胞极化的影响;采用流式细胞术检测巨噬细胞极化情况。结果:心肌梗死1 d后,核仁素表达减少,3 d后表达增加,5 d后明显升高,达(2.73±0.47)倍,7 d后有所下降。小鼠心肌梗死2 d、5 d后,心肌中巨噬细胞明显增多;心肌梗死2 d后心肌中M1型巨噬细胞占77.71%,而心肌梗死5 d后心肌中M2型巨噬细胞占82.13%。核仁素低表达可抑制心肌梗死5 d后M2型巨噬细胞的极化,但对巨噬细胞的侵润无明显影响,可明显减少心肌梗死后28 d的存活率。核仁素过表达可使巨噬细胞极化相关基因NOTCH1和STAT6的mRNA水平表达上调,而核仁素低表达可下调NOTCH1和STAT6的mRNA表达水平。结论:核仁素可调控心梗后巨噬细胞的极化,核仁素低表达可增加小鼠心梗后死亡率。
作者:蒋碧梅;吕青兰;李媛彬;刘梅冬;刘可;涂自智;肖献忠 刊期: 2016年第08期
AIM:MicroRNAs ( miRNAs) were recognized to play significant roles in cardiac hypertrophy .But, it remains unknown whether cyclin/Rb pathway is modulated by miRNAs during cardiac hypertrophy .This study investigates the potential roles of microRNA-1 (miR-1) and microRNA-16 (miR-16) in modulating cyclin/Rb pathway during cardiomyocyte hypertrophy .METHODS:An animal model of hypertrophy was established in a rat with abdominal aortic constriction (AAC).In addition, a cell model of hypertrophy was also achieved based on PE-promoted neonatal rat ventricular cardiomyocyte .RESULTS:miR-1 and-16 expression were markedly de-creased in hypertrophic myocardium and hypertrophic cardiomyocytes in rats .Overexpression of miR-1 and -16 suppressed rat cardiac hypertrophy and hypertrophic phenotype of cultured cardiomyocytes .Expression of cyclins D1, D2 and E1, CDK6 and phosphorylated pRb was increased in hypertrophic myocardium and hypertrophic cardiomyocytes , but could be reversed by enforced expression of miR-1 and -16.CDK6 was validated to be modulated post-transcriptionally by miR-1, and cyclins D1, D2 and E1 were further validated to be modulated post-transcriptionally by miR-16.CONCLUSION: Attenuations of miR-1 and -16 provoke cardiomyocyte hypertrophy via derepressing the cyclins D1, D2, E1 and CDK6, and activating cyclin/Rb pathway.
作者: 刊期: 2016年第08期
目的:建立体外培养人肺内微小动脉的方法,并观察其收缩的基本特性,为研究药物及各种活性因子对人肺血管的长期作用提供有效的实验模型。方法:取癌旁5 cm以上的肺组织,于冰浴和无菌条件下,利用显微操作分离出肺内微小动脉,制备成1.8~2.0 mm长的血管条,分2组,一组急性分离组(新鲜组)马上进行血管张力测定;另一组(培养组)置于含DMEM-F12培养基(内含10%胎牛血清、1%青链霉素)的培养皿内,通以95%O2、5%CO2混合气,在37℃的条件下培养48 h。进行血管张力测定时,用2根直径40μm的不锈钢丝平行穿过血管腔,钢丝的4个端分别固定于微血管张力测定仪浴槽内钳夹的4个螺丝上,采用累积给药法,分别给予血管受体依赖性收缩剂血栓素A2类似物U46619和内皮素-1(ET-1),血管非受体依赖性收缩剂60 mmol/L KCl,然后测定血管的张力变化。结果:培养组对血管收缩剂U46619和ET-1能产生浓度依赖性收缩,U46619的pD2为7.60±0.10,Emax为(136.40±6.17)%;ET-1的pD2为(7.17±0.22),Emax为(137.14±5.52)%,结果类似于新鲜组, U46619的pD2为7.78±0.11,Emax为(131.29±3.79)%;ET-1的pD2为7.53±0.15,Emax为(139.11±6.66)%,两组比较均无显著差异。培养组对血管非受体依赖性收缩剂60 mmol/L KCl产生的收缩力Emax为(7.67±0.85) mN;新鲜组的Emax为(7.73±0.97) mN,两组比较无显著差异。结论:采用血管器官培养的方法培养人肺内微小动脉48 h,能维持血管平滑肌的基本收缩特性,可作为研究各种物质对血管长效作用的有效模型。
作者:邝素娟;杨慧;李晓红;刘晓颖;饶芳;单志新;林秋雄;杨敏;余细勇;吴书林;邓春玉 刊期: 2016年第08期
目的:观察中电导钙激活钾离子通道(intermediate-conductance Ca2+-activated K +channel, KCa3.1)在软脂酸(palmitic acid, PA)诱导的单核细胞跨内皮迁移中的作用及其调控机制。方法:分离2型糖尿病(type 2 diabetes mellitus, T2DM)患者外周血单核细胞(peripheral blood mononuclear cells , PBMCs)并培养人单核细胞株(THP-1 cells),以PA刺激,通过Western blotting、RT-PCR、ELISA及细胞迁移实验观察PA对PBMCs及THP-1细胞跨内皮迁移的影响及其与KCa3.1的关系、KCa3.1与MCP-1之间的关系并探讨其信号转导通路。结果:100μmol/L PA上调体重指数(body mass index, BMI)位于20~27.9 kg/m2的T2DM患者PBMCs KCa3.1的表达并促进其跨内皮迁移,对BMI≥28 kg/m2的T2DM患者PBMCs无影响;KCa3.1特异性阻滞剂TRAM-34、NF-κB阻滞剂PDTC(100μmol/L)和Bay11-7082(10μmol/L)抑制PA诱导的BMI位于20~27.9 kg/m2的T2DM患者PBMCs跨内皮迁移;TRAM-34和KCa3.1特异性siRNA显著减少PA(200μmol/L)诱导的THP-1细胞跨内皮迁移及THP-1细胞中MCP-1的分泌和表达,anti-TLR2/4(4 mg/L)、p38MAPK抑制剂SB203580(10μmol/L)及 SB202190(10μmol/L)、PDTC(100μmol/L)和Bay11-7082(10μmol/L)显著减少PA诱导的THP-1细胞中KCa 3.1和MCP-1的表达。结论:PA通过TLR2/4-p38MAPK-NF-κB通路上调KCa3.1促进MCP-1的表达,进而诱导单核细胞的跨内皮迁移。
作者:马晓真;赵丽梅;庞正达;邓秀玲 刊期: 2016年第08期
目的:构建人食管鳞状细胞癌组织来源的移植瘤模型,并了解其病理学特征和增殖相关的信号通路活化情况。方法:将人食管癌组织移植于重度联合免疫缺陷( SCID)小鼠皮下,待移植瘤长成后对其进行鼠间连续传代。观察第1、第2、第3代移植瘤的生长特性。并对患者肿瘤组织、第1代和第3代移植瘤进行HE染色和CK5/6、p63、p40免疫组织化学染色分析。 Western blot实验检测4例所建立的移植瘤中mTOR、p-mTOR、p70S6K、p-p70S6K、Akt1、p-Akt ( Ser473)、Erk1/2和p-Erk1/2的表达情况。结果:成功建立移植瘤模型,移植瘤生长稳定并能连续传代。各移植瘤组织病理组织类型和CK5/6、p63、p40表达阳性与患者肿瘤组织一致。而在不同病人来源的移植瘤组织中信号转导通路蛋白的活化程度差异有统计学意义。结论:成功建立了人食管鳞状细胞癌组织来源的食管癌移植瘤模型,初步论证该模型能够反映患者的病理特征。
作者:金玉茜;李珂;尹学善;谢祎飞;王艳红;赵四敏;江亚南;赵继敏;赵松;田芳;路静;刘康栋;董子明 刊期: 2016年第08期